Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nelfinavir plus gemcitabine/cisplatin chemoradiotherapy in locally advanced pancreatic carcinoma
2008-006302-42Phase 4Completed
- Sponsor
- University of Oxford
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of nelfinavir in pancreatic cancer (PC), ampullary adenocarcinoma and Not Applicable, sponsored by University of Oxford. Primary endpoint: One-year overall survival. Started Apr 2009; status: completed.
02
Drugs
nelfinavir
03
Conditions
pancreatic cancer (PC)ampullary adenocarcinomaNot Applicable
Beyond the preview
Go deeper on 2008-006302-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006302-42.